Clinical study on norfloxacin in children
Okada, K.; Kagami, S.
Japanese Journal of Antibiotics 43(5): 890-894
1990
ISSN/ISBN: 0368-2781 PMID: 2391761 Document Number: 353236
Norfloxacin (NFLX, AM-715), a new synthetic antibacterial agent, was administered to 18 child patients with infectious diseases. The patients included 5 boys and 13 girls from 3 to 14 years of ages. They were given orally dosage ranging 5.2 .apprx. 17.9 mg/kg/day for 4 to 14 days. Clinical efficacies were excellent in 1 case, good in 16 cases, unknown in 1 case, hence the total efficacy rate was determined to be 100%. There were no cases which showed side effects of the drug and no abnormal laboratory test values were observed during the treatment.